Linyan Tang

Dr. Linyan Tang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in Blood
Verified
Journal Article
Open access
PDF file
PBPhilipp Burkard
Philipp Burkard
CSCharlotte Schonhart
Charlotte Schonhart
TVTimo Vögtle
Timo Vögtle
DKDavid Köhler
David Köhler
LTLinyan Tang
Linyan Tang
BNBernhard Nieswandt
Bernhard Nieswandt
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with high morbidity and mortality. Excessive neutrophil infiltration into the pulmonary airspace is the main cause for the acute inflammation and lung injury. Platelets have been implicated in the pathogenesis of ALI/ARDS, but the underlying mechanisms are not fully understood. Here, we show that the immunoreceptor tyrosine-based activation motif–coupled immunoglobulin-like platelet receptor, glycoprotein VI (GPVI), plays a key role in the early phase of pulmonary thrombo-inflammation in a model of lipopolysaccharide (LPS)-induced ALI in mice. In wild-type (WT) control mice, intranasal LPS application triggered severe pulmonary and blood neutrophilia, hypothermia, and increased blood lactate levels. In contrast, GPVI-deficient mice as well as anti-GPVI–treated WT mice were markedly protected from pulmonary and systemic compromises and showed no increased pulmonary bleeding. High-resolution multicolor microscopy of lung sections and intravital confocal microcopy of the ventilated lung revealed that anti-GPVI treatment resulted in less stable platelet interactions with neutrophils and overall reduced platelet–neutrophil complex (PNC) formation. Anti-GPVI treatment also reduced neutrophil crawling and adhesion on endothelial cells, resulting in reduced neutrophil transmigration and alveolar infiltrates. Remarkably, neutrophil activation was also diminished in anti-GPVI–treated animals, associated with strongly reduced formation of PNC clusters and neutrophil extracellular traps (NETs) compared with that in control mice. These results establish GPVI as a key mediator of neutrophil recruitment, PNC formation, and NET formation (ie, NETosis) in experimental ALI. Thus, GPVI inhibition might be a promising strategy to reduce the acute pulmonary inflammation that causes ALI/ARDS.

29 May 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
Tiago GranjaTiago Granja
Tiago Granja
DKDavid Köhler
David Köhler
LTLinyan Tang
Linyan Tang
PBPhilipp Burkard
Philipp Burkard
CEClaudia Eggstein
Claudia Eggstein
PRPeter Rosenberger
Peter Rosenberger
Pulmonary defense mechanisms are critical for host integrity during pneumonia and sepsis. This defense is fundamentally dependent on the activation of neutrophils during the innate immune response. Recent work has shown that semaphorin 7A (Sema7A) holds significant impact on platelet function, yet its role on neutrophil function within the lung is not well understood. This study aimed to identify the role of Sema7A during pulmonary inflammation and sepsis. In patients with acute respiratory distress syndrome (ARDS), we were able to show a correlation between Sema7A and oxygenation levels. During subsequent workup, we found that Sema7A binds to the neutrophil PlexinC1 receptor, increasing integrins, and L-selectin on neutrophils. Sema7A prompted neutrophil chemotaxis in vitro and the formation of platelet-neutrophil complexes in vivo. We also observed altered adhesion and transmigration of neutrophils in Sema7A−/−animals in the lung during pulmonary inflammation. This effect resulted in increased number of neutrophils in the interstitial space of Sema7A−/− animals but reduced numbers of neutrophils in the alveolar space during pulmonary sepsis. This finding was associated with significantly worse outcome of Sema7A−/− animals in a model of pulmonary sepsis. Sema7A has an immunomodulatory effect in the lung, affecting pulmonary sepsis and ARDS. This effect influences the response of neutrophils to external aggression and might influence patient outcome. This trial was registered at www.ClinicalTrials.gov as #NCT02692118.

6 May 2025 in Neural Regeneration Research
Verified
Journal Article
Open access
LTLinyan Tang
Linyan Tang
ZSZhi Song
Zhi Song
JWJie Wang
Jie Wang
SHShenghua He
Shenghua He
CLChao Liu
Chao Liu
Spinal cord injury is a severe neurological condition with limited neuronal regeneration and functional recovery. Currently, no effective treatments exist to improve spinal cord injury prognosis. Neuronal guidance proteins are a diverse group of molecules that play crucial roles in axon and dendrite growth during nervous system development. Increasing evidence highlights their regulatory functions in spinal cord injury. This review provides a brief overview of the modulation patterns of key neuronal guidance proteins in neuronal axon growth during nervous system formation and subsequently focuses on their roles in neuronal regeneration and functional recovery following spinal cord injury. Neuronal guidance proteins include, but are not limited to, semaphorins and their receptors, plexins; netrins and their receptors, deleted in colorectal cancer and UNC5; Eph receptors and their ligands, ephrins; Slit and its receptor, Robo; repulsive guidance molecules and their receptor, neogenin; Wnt proteins and their receptor, Frizzled; and protocadherins. Localized Netrin-1 at the injury site inhibits motor axon regeneration after adult spinal cord injury while promoting oligodendrocyte growth. Slit2 enhances synapse formation in the injured spinal cord of rats. EphA7 regulates acute apoptosis in the early pathophysiological stages of spinal cord injury, while ephrinA1 plays a role in the nervous system’s injury response, with its reduced expression leading to impaired motor function in rats. EphA3 is upregulated following spinal cord injury, promoting an inhibitory environment for axonal regeneration. After spinal cord injury, bidirectional activation of ephrinB2 and EphB2 in astrocytes and fibroblasts results in the formation of a dense astrocyte-meningeal fibroblast scar. EphB1/ephrinB1 signaling mediates pain processing in spinal cord injury by regulating calpain-1 and caspase-3 in neurons. EphB3 expression increases in white matter after spinal cord injury, further inhibiting axon regeneration. Sema3A, expressed by neurons and fibroblasts in the scar surrounding the injury, inhibits motor neuron and sensory nerve growth after spinal cord injury. Sema4D suppresses neuronal axon myelination and axon regeneration, while its inhibition significantly enhances axon regeneration and motor recovery. Sema7A is involved in glial scar formation and may influence serotonin channel remodeling, thereby affecting motor coordination. Given these findings, the local or systemic application of neuronal guidance proteins represents a promising avenue for spinal cord injury treatment.

4 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JWJie Wang
Jie Wang
DLDeying Li
Deying Li
XPXianghong Peng
Xianghong Peng
ZSZhi Song
Zhi Song
LTLinyan Tang
Linyan Tang
Neurotransmitters, including acetylcholine (ACh) and dopamine, play critical roles in regulating immune cell function and inflammatory responses across various pathologies. Beyond its classical neuronal role, ACh is actively secreted by diverse immune populations, including T cells, B cells, macrophages, dendritic cells, and natural killer cells. Upon binding to nicotinic (nAChRs) and muscarinic (mAChRs) acetylcholine receptors expressed on neutrophils, T cells, B cells, and monocytes/macrophages, ACh triggers intracellular signaling pathways that modulate immune cell proliferation, polarization, and cytokine secretion. Similarly, dopamine receptors (D1R–D5R) are widely expressed across these identical immune cell subsets. Dopamine signaling dynamically orchestrates immune cell proliferation, differentiation, activation, migration, polarization, and cytokine profiles. Consequently, these neurotransmitter-mediated pathways play pivotal roles in the pathogenesis of neurodegenerative, autoimmune, and systemic inflammatory diseases, including Parkinson’s disease, multiple sclerosis, inflammatory bowel disease, acute pancreatitis, chronic obstructive pulmonary disease, acute respiratory distress syndrome, infective endocarditis, and rheumatic heart disease.